Dr. Yasser M. Bhat, MD

Dr. Bhat practices at Surgery Center San Carlos in San Carlos, California.

Dr. Bhat's NPI, 1891896320, was assigned on September 26, 2006. Dr. Bhat graduated from Kasturba Med College Mangalore in 1998. Dr. Bhat holds California license A104393.

Dr. Bhat's primary practice is Surgery Center San Carlos, at 301 Industrial Road Suite 1se, San Carlos, CA 94070.

Dr. Bhat's primary practice is Surgery Center San Carlos in San Carlos, California. Dr. Bhat is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Palo Alto Foundation Medical Group. Dmand AI also links Dr. Bhat to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bhat practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Bhat's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Bhat is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Bhat's licenses on file in 3 states: California, Pennsylvania and Ohio.

Dmand AI lists acid reflux, colonoscopy, gastrointestinal bleeding, pancreas or bile duct endoscopy (ERCP) and upper GI endoscopy among the conditions Dr. Bhat treats.

CMS data shows 1,268 Medicare services from Dr. Bhat across 25 procedure codes in 2024, for 552 Medicare patients. Medicare paid $145,095 for them.

CMS counts 552 Medicare patients who saw Dr. Bhat in 2024. The largest group is 75 to 84, with 261 patients. 74% of them have high cholesterol, and 68% have high blood pressure. 7% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bhat's median patient age at 59, with 52% women.

In 2024, Dr. Bhat wrote 471 Medicare Part D claims for 337 patients. 84% of them were for generic drugs. CMS names the drug for 431 of them, across 8 drugs with 11 or more claims each, at $18,645 in total drug cost. In 2023, CMS named 346 claims across 6 drugs.

Dr. Bhat accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bhat as offering telehealth. CMS counts 804 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Bhat, more than 99% of the clinicians it reports for that procedure.

Dmand AI links 64 papers to Dr. Bhat, published from 2007 to 2023. 2013 was the busiest year, with 12. The most frequent topics are Endosonography, Stents and Cholangiopancreatography, Endoscopic Retrograde. Dr. Bhat has published most often in Gastrointest Endosc. Dr. Bhat's most frequent co-authors are Kenneth F. Binmoeller, MD, Janak N. Shah, MD and Klaus T. Gottlieb, MD.

Dmand AI links Dr. Bhat to 1 clinical trial.

CMS Open Payments shows 53 general payments to Dr. Bhat from 16 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Boston Scientific Corporation paid the most, $2,588.

Dr. Bhat graduated from Kasturba Med College Mangalore in 1998.

Dr. Bhat is in network with 13 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.